Source: European Parliament
B10‑0067/2024
Motion for a European Parliament resolution on the creation of a European fund, financed by the extraordinary profits from ‘COVID-19 vaccines’, to compensate victims and to finance research into the treatment of long COVID and its persistent side-effects
The European Parliament,
– having regard to Rule 149 of its Rules of Procedure,
A. whereas extraordinary profits were made by Pfizer (35 billion), BioNTech (20 billion) and Moderna (20 billion) in 2021/2022[1];
B. whereas 1.7 million adverse – and sometimes very serious – reactions have been reported to the European Medicines Agency[2];
C. whereas, according to the European Medicines Agency, 12 000 people have died in the European Union from COVID-19 vaccines:
D. whereas 17 million people have reportedly experienced persistent symptoms after contracting COVID-19 or after being vaccinated against it[3];
1. Calls on the European Commission to create a fund, financed by the extraordinary profits from ‘COVID-19 vaccines’, to compensate victims and to finance research into the treatment of long COVID and its persistent side-effects;
2. Instructs its President to forward this resolution to the Commission and the Member States.